Navigation Links
Diabetes Drug Byetta May Aid Weight Loss in Obese Patients
Date:6/11/2009

Combined diet, exercise and injection had best results in study

THURSDAY, June 11 (HealthDay News) -- Exenatide (Byetta), a drug normally used to treat diabetes, may also help non-diabetic obese people lose weight when combined with diet and exercise, new research has found.

Researchers divided 152 obese men and women (with a body-mass index of greater than 30 and an average weight of 241 pounds) into two groups. About 25 percent of the study participants had impaired glucose tolerance, which can be a precursor to diabetes.

One group received 10 micrograms of exenatide twice a day, while the other received a placebo. Both groups were put on a diet and exercise program for 24 weeks, according to the study authors.

After six months, those taking exenatide lost three times more weight than those taking the placebo, the researchers found. Participants taking exenatide lost an average of 11 pounds, while those in the placebo group lost 3.5 pounds on average.

Some 9.6 percent of exenatide-treated participants lost more than 10 percent of their body weight, according to the study authors.

"Drug therapy is considered important adjunctive treatment to diet and exercise in the successful management of obesity," Dr. Michael Trautmann, a researcher with Eli Lilly in Indianapolis, said in a news release from the Endocrine Society. "To date, however, there are few effective drugs that help obese people lose weight."

The study was to be presented Thursday at the annual meeting of the Endocrine Society in Washington, D.C.

Previous research has shown that exenatide, an injectable medication marketed by Amylin Pharmaceuticals and Eli Lilly and Company under the brand name Byetta, can help lower blood sugar and helps some diabetics lose weight. The current study was funded by the pharmaceutical companies.

The most common side effects of exenatide were mild or moderate nausea and diarrhea. No participants reported low blood sugar, the researchers note.

Exenatide may promote weight loss by causing people to eat less and increasing feelings of fullness, Trautmann said.

More information

The U.S. Centers for Disease Control and Prevention offers more on obesity.



-- Jennifer Thomas



SOURCE: Endocrine Society, news release, June 10, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Adverse housing conditions contribute to diabetes risk
2. RAND finds cases of undiagnosed diabetes drop sharply
3. UCLA researchers identify markers that may predict diabetes in still-healthy people
4. Diabetes appears to increase risk of death for patients with acute coronary syndromes
5. Discovery of sugar sensor in intestine could benefit diabetes
6. Despite overeating, morbidly obese mice gain protection against diabetes
7. Heart Attack Boosts Diabetes Risk
8. Obesity Doesnt Always Equal Diabetes
9. Sugary Sodas High in Diabetes-Linked Compound
10. Treating diabetes during pregnancy can break link to childhood obesity
11. Treating Diabetes During Pregnancy Could Lead to Thinner Kids
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Diabetes Drug Byetta May Aid Weight Loss in Obese Patients
(Date:6/27/2016)... ... June 27, 2016 , ... ... announced today its affiliation with Tennessee Counseling Association. This new relationship ... of the Tennessee Counseling Association, adding exclusive benefits and promotional offers. , "TCA ...
(Date:6/26/2016)... ... , ... Quality metrics are proliferating in cancer care, and are derived from ... of the beholder, according to experts who offered insights and commentary in the current ... For the full issue, click here . , For the American Society of ...
(Date:6/26/2016)... Charlotte, NC (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind ... able to be personalized through a fitness app. The fitness app plans to fix the ... solutions currently only offer a one size fits all type program , They ...
(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 ... brings up a new, often overlooked aspect of head lice: the parasite’s ability to live ... not a common occurrence, but a necessary one in the event that lice have simply ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... , June 26, 2016 One of Australia,s ... announced the formation of a new biotechnology company, Noxopharm Limited [ABN ... in an IPO and to list on the ASX. ... NOX66, ready to enter a Phase 1 clinical study later this ... to address one of the biggest problems facing cancer patients - ...
(Date:6/26/2016)... DUBLIN , June 27, 2016 Jazz ... the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act ... proposed acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... 11:59 p.m. (Eastern Daylight Time). As previously ... entered into a definitive merger agreement under which Jazz ...
(Date:6/26/2016)... 27, 2016  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ... whatever measures required to build a strong and stable ... currently listed on the OTC Markets-pink current trading platform. ... CEO, "We are seeing an anomaly in market trading ... only by the Company, but shareholders and market players ...
Breaking Medicine Technology: